Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 1
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: BLA 1, NDA 1.
| Dosage form | NDCs |
|---|---|
| injection, powder, for solution | 1 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| intravenous | 1 |
| oral | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| pharming healthcare inc. | 2 |
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8653092 | JOENJAleniolisib phosphate | substance, product | Feb 2032 |
| Product | Exclusivity | Until |
|---|---|---|
| JOENJALENIOLISIB PHOSPHATE | ODE-430 Orphan drug | Mar 2030 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Joenja | Leniolisib | tablet, film coated, oral | 71274-170NDA |
| Ruconest | c1 esterase inhibitor recombinant | injection, powder, for solution, intravenous | 71274-350BLA |
Enquiry
Common questions
- Is Pharming Healthcare Inc. FDA approved?
- Pharming Healthcare Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Pharming Healthcare Inc. make?
- 2 products are listed under Pharming Healthcare Inc. in the openFDA NDC Directory, most often as injection, powder, for solution; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.